Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients

BACKGROUND: The second-and third-generation drug-eluting stents (DESs) in-stent restenosis (ISR) genetic risk score (GRS) model has been previously validated. However, the model has not been validated in geriatric patients. Therefore, we conducted this study to test the feasibility of the DES-ISR GR...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Yu-Ling, Huang, Mu-Shiang, Chang, Hsien-Yuan, Lee, Cheng-Han, Chen, Dao-Peng, Li, Yi-Heng, Chao, Ting-Hsin, Liu, Yen-Wen, Liu, Ping-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357661/
https://www.ncbi.nlm.nih.gov/pubmed/37468836
http://dx.doi.org/10.1186/s12877-023-04103-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357661/
https://www.ncbi.nlm.nih.gov/pubmed/37468836
http://dx.doi.org/10.1186/s12877-023-04103-w

Ejemplares similares